Long-term effects of allergy shots in children
Part of Immune system & allergy clinical trials.
This study looks at how well allergy shots or drops work over the long term in children who received this treatment at Odense University Hospital. It aims to understand if the benefits last for years after treatment ends.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been treated with allergy shots or drops (allergen immunotherapy) at Odense University Hospital's children's clinic.
- Your treatment must have lasted for at least 12 months. If it was shorter, this trial is not for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks on children and young people 5 to 15 years after they finished an 18-month oral immunotherapy treatment for peanut, egg, or milk allergy. It helps researchers understand how their allergies and health are doing over the long term.
This study checks how well a newer, detailed allergy test (using specific allergen components) can guide whether you should get allergy immunotherapy (allergy shots) for things like dust mites or grass pollen. It may help patients get the right treatment plan by improving how doctors confirm what allergens are driving symptoms.
This study looks at how immune cells work in people with allergic conjunctivitis and whether allergy shots (desensitization therapy) can help. It aims to understand the balance of certain immune cells in your eyes and blood.
This trial collects information from people of all ages who have allergic rhinitis, conjunctivitis, or asthma and are prescribed allergy immunotherapy (shots or drops). The goal is to understand how these treatments work in real life.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
Hear when a new Allergy in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.